Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:1440-1445

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, T.
Right arrow Articles by Benedict, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, T.
Right arrow Articles by Benedict, C. R.
Related Collections
Right arrow Mechanism of atherosclerosis/growth factors

(Circulation. 2001;103:1440.)
© 2001 American Heart Association, Inc.


Basic Science Reports

Lysophosphatidylcholine and Reactive Oxygen Species Mediate the Synergistic Effect of Mildly Oxidized LDL With Serotonin on Vascular Smooth Muscle Cell Proliferation

Takuya Watanabe, MD; Rajbabu Pakala, PhD; Shinji Koba, MD; Takashi Katagiri, MD; Claude R. Benedict, MD, DPhil

From the Department of Internal Medicine, Division of Cardiology, University of Texas-Houston Health Science Center (T.W., R.P., C.R.B.), and Third Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan (S.K., T.K.).

Correspondence to Claude R. Benedict, MD, DPhil, Department of Internal Medicine, Division of Cardiology, The University of Texas-Houston Health Science Center, 6431 Fannin, MSB 6.039, Houston, TX 77030. E-mail c.benedic{at}heart.med.uth.tmc.edu

Background—Mild oxidation of LDL enhances its atherogenic potential and induces a synergistic interaction with serotonin (5HT) on vascular smooth muscle cell (VSMC) proliferation. Because of its complex chemical nature, the mitogenic components of mildly oxidized LDL (moxLDL) remain unclear.

Methods and Results—We examined both the effects of lysophosphatidylcholine (LPC) and hydrogen peroxide (H2O2), a donor of reactive oxygen species, as major components of moxLDL and their interactions with 5HT on VSMC proliferation. Growth-arrested VSMCs were incubated with different concentrations of moxLDL, LPC, H2O2, or LPC with H2O2 in the absence or presence of 5HT. DNA synthesis in VSMCs was examined by [3H]thymidine incorporation. MoxLDL, LPC, H2O2, and 5HT stimulated DNA synthesis in a dose-dependent manner. MoxLDL had a maximal stimulatory effect at a concentration of 5 µg/mL (211%), LPC at 15 µmol/L (156%), H2O2 at 5 µmol/L (179%), and 5HT at 50 µmol/L (205%). Added together, moxLDL (50 ng/mL) and 5HT (50 µmol/L) synergistically increased DNA synthesis (443%). Coincubation of LPC (1 µmol/L) with H2O2 (0.5 µmol/L) and 5HT (5 µmol/L) resulted in a synergistic increase in DNA synthesis (439%), which was nearly equal to that of moxLDL with 5HT (443%). The combined effects of LPC, H2O2, and 5HT on DNA synthesis were completely reversed by the combined use of an antioxidant, N-acetylcysteine (400 µmol/L) or butylated hydroxytoluene (20 µmol/L), with a 5HT2 receptor antagonist, LY281067 (10 µg/mL).

Conclusions—Our results suggest that both LPC and reactive oxygen species may contribute to the mitogenic effect of moxLDL on VSMCs and its synergistic effect with 5HT.


Key Words: antioxidants • atherosclerosis • lipoproteins • muscle, smooth • platelet-derived factors




This article has been cited by other articles:


Home page
Diabetes CareHome page
M. Fukui, H. Ose, G. Hasegawa, T. Yoshikawa, and N. Nakamura
Association Between Urinary Albumin Excretion and Plasma 5-Hydroxyindole-3-Acetic Acid Concentration in Men With Type 2 Diabetes
Diabetes Care, October 1, 2007; 30(10): 2649 - 2651.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Damirin, H. Tomura, M. Komachi, J.-P. Liu, C. Mogi, M. Tobo, J.-Q. Wang, T. Kimura, A. Kuwabara, Y. Yamazaki, et al.
Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2513 - H2522.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Rius, J. Martinez-Gonzalez, J. Crespo, and L. Badimon
Involvement of Neuron-Derived Orphan Receptor-1 (NOR-1) in LDL-Induced Mitogenic Stimulus in Vascular Smooth Muscle Cells: Role of CREB
Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 697 - 702.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
I. GOUNI-BERTHOLD and A. SACHINIDIS
Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells?
FASEB J, October 1, 2002; 16(12): 1477 - 1487.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Watanabe, R. Pakala, T. Katagiri, and C. R. Benedict
Synergistic Effect of Urotensin II With Mildly Oxidized LDL on DNA Synthesis in Vascular Smooth Muscle Cells
Circulation, July 3, 2001; 104(1): 16 - 18.
[Abstract] [Full Text] [PDF]